| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | BUY | BUY |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.57▼ | 1.57▼ | 1.56▼ | 1.57▼ | 1.40▲ |
| MA10 | 1.58▼ | 1.58▼ | 1.58▼ | 1.50▲ | 1.43▲ |
| MA20 | 1.62▼ | 1.63▼ | 1.61▼ | 1.43▲ | 1.43▲ |
| MA50 | 1.59▼ | 1.52▼ | 1.50▲ | 1.44▲ | 1.33▲ |
| MA100 | 1.48▲ | 1.45▲ | 1.45▲ | 1.45▲ | 1.83▼ |
| MA200 | 1.43▲ | 1.45▲ | 1.46▲ | 1.38▲ | 2.74▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | -0.015▼ | -0.020▼ | -0.020▼ | 0.023▲ | -0.005▼ |
| RSI | 31.739▼ | 39.264▼ | 41.966▼ | 54.229▲ | 52.710▲ |
| STOCH | 1.667▼ | 1.667▼ | 1.667▼ | 68.372 | 22.623 |
| WILL %R | -100.000▼ | -100.000▼ | -100.000▼ | -51.220 | -58.333 |
| CCI | -182.873▼ | -171.730▼ | -171.730▼ | 56.052 | 86.889 |
|
Saturday, July 04, 2026 04:40 PM
Merck (NYSE:MRK) reported positive Phase 3 results for tulisokibart, an anti-TL1A monoclonal antibody in moderate-to-severe ulcerative colitis. The company announced new FDA approvals for ...
|
|
Wednesday, July 01, 2026 02:52 PM
Merck & Co., Inc. (NYSE:MRK) is one of billionaire Cliff Asness’ top 10 healthcare stock picks. On June 25, Merck & Co., Inc. (NYSE:MRK) announced that the FDA approved both KEYTRUDA and KEYTRUDA ...
|
|
Monday, June 29, 2026 11:53 AM
Merck draws attention as healthcare strength, pharma activity, and defensive market rotation place large drugmakers back in focus.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 10/07/26 | 1.59 | 1.59 | 1.51 | 1.51 | 70,894 |
| 09/07/26 | 1.59 | 1.6093 | 1.56 | 1.58 | 38,954 |
| 08/07/26 | 1.67 | 1.70 | 1.59 | 1.61 | 132,037 |
| 07/07/26 | 1.5399 | 1.72 | 1.52 | 1.68 | 227,990 |
| 06/07/26 | 1.47 | 1.60 | 1.46 | 1.48 | 148,002 |
| 02/07/26 | 1.46 | 1.52 | 1.46 | 1.47 | 53,763 |
| 01/07/26 | 1.46 | 1.498 | 1.45 | 1.45 | 46,548 |
| 30/06/26 | 1.48 | 1.4929 | 1.41 | 1.47 | 51,743 |
| 29/06/26 | 1.33 | 1.46 | 1.33 | 1.46 | 97,854 |
| 26/06/26 | 1.31 | 1.36 | 1.31 | 1.315 | 66,842 |
|
|
||||
|
|
||||
|
|